-

Research, Eastern Virginia Medical School (EVMS) Funding

Current

  • 1/14 - $30,000 – Cristina Baldassari, M.D.
    Urinary Leukotriene E4 Levels in Children with Obstructive Sleep Apnea
  • 5/11 - $43,424 – Eric Dobratz, M.D.
    Comparison of decelullarized vs. gamma irradiated septal and costal cartilage allografts.
  • 4/13 - $49,996 – Barry Strasnick, M.D.
    Ototoxicity Therapies (Phase 1 funding for Jellyfish Model for Ototoxicity).
  • 8/14 - $50,000 – Vivian Wu, M.D.
    Unravelling the cellular hierarchy within human tonsilar crypt epithelium and oropharyngeal squamous cell carcinoma tumors.

Complete

  • 1/14 -$30,000 – Cristina Baldassari, M.D.
    Urinary Leukotriene E4 Levbels in Children with Obstructive Sleep Apnea
  • 5/11 - $43,424 – Eric Dobratz, M.D.
    Comparison of decelullarized vs. gamma irradiated septal and costal cartilage allografts.
  • 5/10 -$49,870 – Alireza Hosseini, M.D.
    Inhibiting Vasoproliferation in a Rat Model of Retinopathy of Prematurity with a Novel Topical Anti-Tubulin Drug.
  • 3/11 - $31,779 - Joseph Han, M.D.
    Validation & Limitation of Image Guided Robotic Surgery for the Skull Base.
  • 5/09 - $44,280 – Joseph Han, M.D.
    Immune Response in Chronic Rhinosinusitis.
  • 5/12 - $29,812 – Joseph Han, M.D.
    Interleukins in Chronic Sinusitis.
  • 5/09 -$5,000 – Allen Mitchell, M.D.
    Vascular Delay – Correction of Ablative Defects after Resection of Head and Neck Neoplasms.
  • 5/08 -$49,500 – Sandeep Samudre, PhD
    Anti-Angiogenic Effects of Topically Applied Endocannabinoid Analogs in a Mouse Model of Age-Related Macular Degeneration.
  • 8/11 - $50,000 – Barry Strasnick, M.D.
    Jellyfish Model for Ototoxicity.
  • 4/13 -$49,996 – Barry Strasnick, M.D.
    Ototoxicity Therapies